Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Binghamton, NY MSA — September 2026
Binghamton life sci talent competes against a record-tight NY market.
Binghamton unemployment held at 4.4% while statewide pharma/biotech employment hit a record 23,643 jobs and CRA advertised pay climbed to a metro median of $97,647, intensifying competition for scarce regional talent.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Binghamton metro unemployment: 4.4% — Steady since July 2026; vs 4.3% NY state
- NY pharma/biotech jobs: 23,643 — Record high, Aug 2026 statewide
- BioSpace job postings: -39% YoY — Signals selective, specialty-focused hiring
- CRA advertised pay, metro: $97,647 — vs $90,956 national median, both rising
Key takeaways
Selective national hiring masks local vulnerability to poaching.
BioSpace postings down 39% year-over-year reflects tighter, more targeted hiring nationally, but New York's 38,700 life sciences research professionals remain the largest pool in the country — a magnet pulling Binghamton-based regulatory and quality talent toward higher-paying downstate and Boston-area roles.
CRA pay surge signals execution roles are no longer cheap insurance.
Metro median CRA pay at $97,647 outpaces the national median of $90,956, both trending up significantly — a sign that even mid-tier clinical operations roles are being bid up as sponsors and CROs compete for dwindling monitoring capacity.
Regional wage base makes build-vs-outsource math harder to ignore.
Broome County's roughly $37,000 average wage sits far below the life sciences national base salary range, meaning internal hires for specialized CMC or regulatory functions require premiums well above local norms — a gap that may tilt headcount decisions toward CDMO/CRO partnerships rather than in-house builds.
Healthcare-dominant local economy limits scientific labor supply.
With healthcare and social assistance accounting for 16% of Binghamton's private employment and manufacturing stable near 10,000 workers, the metro's labor base skews toward clinical care delivery rather than life sciences R&D or manufacturing — reinforcing reliance on imported or remote specialized talent.
Median advertised pay by role — Binghamton, NY MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,152 | $121,403 | $148,970 | Moderate increase | $131,354 |
| Clinical Research Associate * | $72,812 | $97,647 | $102,276 | Significant increase | $90,956 |
| Lab Technician * | $40,114 | $46,904 | $50,189 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $70,044 | $96,238 | $116,373 | Moderate decline | $104,000 |
| Clinical Data Manager * | $103,367 | $123,978 | $136,385 | Significant decline | $123,031 |
| Biostatistician * | $109,100 | $140,725 | $175,000 | Moderate increase | $133,322 |
| Validation Engineer * | $95,728 | $105,849 | $119,600 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Binghamton metro unemployment held steady at 4.4% in August against a backdrop of modest regional job growth, with employed residents up 1,500 to 103,800, while healthcare and social assistance remains the dominant local employer base at 16% of private employment. Statewide, New York's life sciences sector hit a record 23,643 pharma and biotech jobs even as BioSpace postings fell 39% year-over-year, signaling employers are hiring selectively and concentrating offers on scarce, credentialed specialties rather than broadening headcount.
What it means
Broome County's thin specialized talent base — concentrated in a healthcare-heavy, lower-wage regional economy where average wages sit near $37,000 against a statewide life sciences environment paying mid-$140K to low-$160K base salaries — means local employers face a structural pay gap when competing for regulatory, quality, or CMC talent against Albany, Boston, or metro NYC sites. National CRA advertised pay climbed to a metro median of $97,647, up significantly from $90,956 nationally, suggesting even execution-level clinical roles now command premiums that strain a thin regional labor pool. Current conditions suggest reviewing whether Binghamton-based clinical, quality, and regulatory roles need geographic pay differentials or remote-eligible structuring to remain competitive against higher-cost hubs drawing the same limited candidate pipeline.
Looking ahead
Worth watching: September's national biopharma layoffs (BioMarin, Bristol Myers) concentrated in consolidation functions rather than execution roles; watch whether any displaced regulatory or quality talent filters into the Binghamton/Southern Tier candidate pool over the next two months.
Emerging pressure point: New York's record 23,643 pharma/biotech jobs statewide, paired with falling postings volume, suggests employers are consolidating demand into fewer, more senior roles — a dynamic that could widen the compensation gap between upstate sites like Binghamton and downstate hubs.
Early indicator: National CRA advertised pay rising significantly in both metro and national medians may foreshadow similar upward pressure on other clinical operations and quality roles locally; organizations should track whether neighboring Albany or Rochester postings begin reflecting comparable increases.
Potential inflection point: WARN activity remains low statewide with no large-scale layoffs reported regionally, but Binghamton's heavy healthcare employment concentration means any shift in hospital system staffing (Guthrie, UHS) could quickly affect the broader clinical talent pool life sciences employers also draw from.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.